Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Firmicutes in Coronary Artery Disease: A Taxonomic-Level Meta-Analysis of Mendelian Randomization Studies.

Current cardiology reviews·2026
Same author

Factors influencing clinical research participation in ophthalmology: a mixed-methods study in keratoconus.

Scientific reports·2026
Same author

Long-Term Comparative Outcomes of TNF-α Antagonists vs. Vedolizumab as First-Line Biologic Therapy for Refractory Ulcerative Proctitis: A Propensity-Matched Study.

Biomedicines·2026
Same author

Clinical Advances in Heart Failure with Preserved Ejection Fraction: A Systematic Review of Therapeutic and Mechanistic Evidence.

Vascular health and risk management·2026
Same author

Artificial Intelligence for Cardiovascular Risk Prediction: An Umbrella Review of Applications and Translational Challenges.

Vascular health and risk management·2026
Same author

Evaluation of Interleukin-1<i>β</i> and Interleukin-6 in the Crevicular Fluid around Healthy Implants and Peri-Implantitis: A Comparative Study.

Journal of pharmacy & bioallied sciences·2026

Related Experiment Video

Updated: Dec 1, 2025

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.3K

NAFLD and COVID-19: a Pooled Analysis.

Sonali Sachdeva1, Harshwardhan Khandait2, Jonathan Kopel3

  • 1Department of Medicine, Lady Hardinge Medical College, New Delhi, India.

SN Comprehensive Clinical Medicine
|November 11, 2020
PubMed
Summary
This summary is machine-generated.

Non-alcoholic fatty liver disease (NAFLD) significantly increases the risk of severe COVID-19 complications. This study confirms NAFLD as an independent predictor of severe outcomes in COVID-19 patients, even when obesity is considered.

Keywords:
COVID-19CoronavirusFatty liverMAFLDNAFLDSARS-CoV-2

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K
Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
08:21

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera

Published on: May 23, 2025

711

Related Experiment Videos

Last Updated: Dec 1, 2025

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.3K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K
Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
08:21

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera

Published on: May 23, 2025

711

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Metabolic syndrome and multimorbidity increase COVID-19 severity.
  • Non-alcoholic fatty liver disease (NAFLD) involves chronic inflammation, potentially exacerbating COVID-19.
  • Compromised liver function in NAFLD may heighten COVID-19 risks.

Purpose of the Study:

  • To investigate the association between NAFLD and severe COVID-19.
  • To determine if NAFLD predicts severe COVID-19 independently of obesity.

Main Methods:

  • Systematic literature review.
  • Meta-analysis of existing studies.

Main Results:

  • NAFLD is a significant predictor of severe COVID-19.
  • The association between NAFLD and severe COVID-19 remains significant after adjusting for obesity (OR 2.358).

Conclusions:

  • NAFLD is an independent risk factor for severe COVID-19.
  • Targeting NAFLD may be crucial for managing COVID-19 patients.